CVRx (CVRX) Liabilities and Shareholders Equity (2020 - 2026)
CVRx (CVRX) posted quarterly Liabilities and Shareholders Equity of $99.7 million for Q1 2026, down 23.04% year-over-year from $129.6 million in Q1 2025, and down 4.83% quarter-over-quarter from $104.8 million in Q4 2025.
CVRx (CVRX) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
CVRx's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $99.7 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 23.04% year-over-year to $99.7 million; the TTM figure through Mar 2026 stood at $435.4 million (down 10.53% YoY), while the FY2025 annual figure was $104.8 million, down 21.45% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $99.7 million, down from $104.8 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $144.4 million in Q1 2022, with the low at $96.0 million in Q2 2024.
- The 5-year median for Liabilities and Shareholders Equity is $119.6 million (2025), against an average of $118.7 million.
- Peak annual rise in Liabilities and Shareholders Equity reached 143.43% in 2022, while the deepest fall reached 30.34% in 2022.
- CVRx's Liabilities and Shareholders Equity stood at $124.9 million in 2022, then fell by 7.77% to $115.2 million in 2023, then climbed by 15.78% to $133.4 million in 2024, then decreased by 21.45% to $104.8 million in 2025, then fell by 4.83% to $99.7 million in 2026.
- Business Quant data shows CVRX's Liabilities and Shareholders Equity at $99.7 million in Q1 2026, $104.8 million in Q4 2025, and $111.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 10.74 Bn |
| 10 | CVRx | 76.50 Mn | 11.91 Mn | 13.72 Mn | 92.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 92.28 Mn |
| Mar 31, 2026 | 99.73 Mn |
| Dec 31, 2025 | 104.79 Mn |
| Sep 30, 2025 | 111.33 Mn |
| Jun 30, 2025 | 119.56 Mn |
| Mar 31, 2025 | 129.59 Mn |
| Dec 31, 2024 | 133.41 Mn |
| Sep 30, 2024 | 127.67 Mn |
| Jun 30, 2024 | 95.98 Mn |
| Mar 31, 2024 | 106.17 Mn |
| Dec 31, 2023 | 115.23 Mn |
| Sep 30, 2023 | 106.40 Mn |
| Jun 30, 2023 | 114.97 Mn |
| Mar 31, 2023 | 122.69 Mn |
| Dec 31, 2022 | 124.94 Mn |
| Sep 30, 2022 | 126.58 Mn |
| Jun 30, 2022 | 134.04 Mn |
| Mar 31, 2022 | 144.41 Mn |
| Dec 31, 2021 | 152.55 Mn |
| Sep 30, 2021 | 181.71 Mn |